Concepedia

Mary Ann Lochner

MA

3

Publications

119

Citations

3

H-Index

1982

Active since

Affiliations

Eli Lilly (United States)(Current)

Mary Ann Lochner is an author at Eli Lilly (United States) specializing in drug discovery, pharmacotherapy, and medicine.

Top concepts

Publications per year

1982–1985

3

Publications

3

Chronic ethanol alters the receptor binding characteristics of the delta opioid receptor ligand, DAla2DLeu5 enkephalin in mouse brain

Martin D. Hynes, Mary Ann Lochner, Kerry G. Bemis et al. · Life Sciences · 1983 · 52 citations

Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptors

Martin D. Hynes, Mary Ann Lochner, Kerry G. Bemis et al. · Life Sciences · 1985 · 48 citations

, , +13

Novel phenylpiperidine opioid antagonists and partial agonists: Effects on fluid consumption

J. David Leander, John C. Hart, Mary Ann Lochner et al. · European Journal of Pharmacology · 1982 · 19 citations

, , +9

Rows per page

1–3 of 3